Publication dates

All regions

Ovarian Cancer Industry, December 2014 Market Reports from Top Publishers

You might be interested in: Cancer, Medical Equipment, Therapeutics, more »


 
1-20 of about 5 900 reports for Ovarian Cancer

Orion Genomics LLC - Product Pipeline Analysis, 2014 Update

Orion Genomics LLC - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • December 2014
  • by Global Data

... Genomics announces the discovery and validation of biomarkers for lung and ovarian cancer 30apr 14, 2007: orion genomics announces the discovery and validation of biomarkers for lung and ovarian cancer ...

Vitatex Inc. - Product Pipeline Analysis, 2014 Update

Vitatex Inc. - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • December 2014
  • by Global Data

... Colorectal cancer ctc detection kit - product status 12colorectal cancer ctc detection kit - product description 12diagnostic test - ovarian cancer - product status 13diagnostic test - ovarian cancer ...

Exploit Technologies Pte Ltd - Product Pipeline Analysis, 2014 Update

Exploit Technologies Pte Ltd - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • December 2014
  • by Global Data

... Exploit technologies pte ltd pipeline products overview 17biomarker - gastric cancer 17biomarker - gastric cancer product overview 17biomarker - ovarian cancer 18 ...

Vascular Biogenics Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Vascular Biogenics Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

... Such as differentiated thyroid cancer, renal cell carcinoma, neuroendocrine tumors, glioblastoma multiforme and ovarian cancer. Vbl is headquartered in or yeh, tel aviv, israel.Vascular biogenics ltd ...

Aposense Ltd. (Symbol:APOS) SWOT Analysis, Strategy, Revenues and Profits

Aposense Ltd. (Symbol:APOS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Of parkinson's disease. The company's att-11t is a therapeutic compound used in the treatment of metastatic solid tumors such as colorectal cancer, lung cancer and ovarian cancer. It markets products through ...

HealthLinx Limited (Symbol:HTX) SWOT Analysis, Strategy, Revenues and Profits

HealthLinx Limited (Symbol:HTX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... And diagnostic products. Its products include cr0014, ovplex, and clear it. Healthlinx's cr014 is an inhibitor of vascular leak; ovplex is a multimarker blood test for ovarian cancer; and clear it is a protein ...

OXiGENE, Inc. (Symbol:OXGN) SWOT Analysis, Strategy, Revenues and Profits

OXiGENE, Inc. (Symbol:OXGN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Trials for the treatment of ovarian cancer, anaplastic thyroid cancer, medullary thyroid cancer, stage iv papillary thyroid cancer, and stage iv follicular thyroid cancer. The company also offers falcon ...

Viralytics Ltd. (Symbol:VLA) SWOT Analysis, Strategy, Revenues and Profits

Viralytics Ltd. (Symbol:VLA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Also provides virotherapy technology that uses group of viruses to target cancer cells. It conducts cancer research on gastric cancer with evatak, ovarian cancer with evatak, and melanoma studies ...

TapImmune Inc. (Symbol:TPIV) SWOT Analysis, Strategy, Revenues and Profits

TapImmune Inc. (Symbol:TPIV) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Hope in breast and ovarian cancerjun 12, 2014: tapimmune appoints leading immunotherapy researcher to chair scientific advisory boardthis comprehensive swot profile of tapimmune inc ...

The University of Texas M. D. Anderson Cancer Center SWOT Analysis, Strategy, Revenues and Profits

The University of Texas M. D. Anderson Cancer Center SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Houston areajul 14, 2014: md anderson researchers discover new route for ovarian cancer spreadjun 17, 2014: bd signs agreement for installation of the bd cato workflow solution in leading cancer ...

About 900 reports for Ovarian Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • August 2014
    25 pages
  • Cancer  

    Breast Cancer  

  • United States  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.